The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly, treatment adherence and engagement in study protocols are critical for clinical trial success.
Every research participant who discontinues study drug, fails to provide clinical data, or drops out of a study, reduces its statistical power, and may bias the results, impacting credibility. In this webinar, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting.
The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research.
Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful, effective approaches should apply the findings from behavioral science, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial, a valid assessment of patients’ beliefs, attitudes and behaviors allows for rational and personalized interventions, including solutions using digital tools.
Register for this webinar today to explore how evidence-based behavioral frameworks, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials.
Speakers
Dr. Nicholas Alp, MD, PhD, FACC, Chief Medical Officer, Clinical ink
Dr. Nicholas Alp is Chief Medical Officer of Clinical ink, a digital health technology company focused on clinical development. With more than 30 years’ experience as an Academic Cardiologist, Clinical Trialist and Drug Development Expert, he has held senior leadership roles at Oxford University, and at the Clinical Research Organizations ICON and Medpace. He has published more than 70 peer-reviewed articles.
Message Presenter
Kevin Dolgin, MRes, MBA, Co-founder, Observia
Kevin Dolgin is the Co-founder of Observia, a French company specializing in patient support services. He has worked in healthcare since 1992 in over sixty countries. Kevin is also an Affiliate Professor at the University of Paris (IAE – Paris I, Panthéon-Sorbonne). He has been widely published in both trade and scientific publications around the world, and has spoken at, and chaired, numerous trade and academic conferences in healthcare. Kevin has a BA in Economics from Fordham University, an MBA from INSEAD and a Master of Research from the Sorbonne.
Message Presenter
Dr. John D. Piette, MS, PhD, Professor of Global Public Health, University of Michigan
Dr. John Piette is a Professor of Global Public Health at the University of Michigan. His research focuses on evidence-based behavioral approaches and artificial intelligence to improve healthcare for chronically ill patients.
He has published more than 350 peer-reviewed papers, and his program for training and delivery of behavioral health services has been embraced by governmental and community organizations in Mexico and Central America. Dr. Piette currently focuses on advancing the science on AI applications for behavior change and capacity-building for self-management support globally.
Message PresenterWho Should Attend?
This webinar will appeal to those working in the following areas or those having the following titles:
- Medium-to-Large Pharma and CROs
- Medical Device Manufacturers
- Director/VP/Head of Precision Medicine
- Chief Medical Director
- Director/VP/Head of Digital Innovation/Engagement
- Scientists/Engineers/Data Scientists
What You Will Learn
Attendees will learn about:
- An appreciation of the impact of patient’s attitudes, beliefs, barriers and behavior in clinical practice and clinical trials
- The tools available to carry out a behavioral diagnosis to predict and understand adherence risk
- The personalized strategies available to improve patients’ engagement in treatment and trials to preserve study power and enhance study integrity
Xtalks Partner
Clinical ink
Clinical ink is a global life science company bringing data, technology, and patient-centric research together. Our deep therapeutic area expertise, coupled with Direct Data Capture, eCOA, behavioral and dropout prediction, eConsent, telehealth, and digital biomarkers advancements (including use of Continuous Glucose Monitoring for detection of hypoglycemia), support the next generation of clinical trials and ultimately the clinical management of patients.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account